Glaukos (GKOS) - P/S ratio

P/S ratio as of November 2026 (TTM): 19.4

According to Glaukos's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 18.6. At the end of 2026 the company had a P/S ratio of 14.0.

P/S ratio history for Glaukos from 2015 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	14.0	11.65%
2025	12.5	-42.34%
2024	21.7	76.33%
2023	12.3	67.32%
2022	7.37	3.94%
2021	7.09	-52.88%
2020	15.0	50.44%
2019	10.00	-10.63%
2018	11.2	100.96%
2017	5.57	-44.66%
2016	10.1	-9.23%
2015	11.1

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
ICU Medical ICUI	2.01	-89.63%	🇺🇸 USA
AtriCure ATRC	5.28	-72.76%	🇺🇸 USA
Integra LifeSciences IART	0.6547	-96.62%	🇺🇸 USA
Hill-Rom HRC	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Glaukos (GKOS)

P/S ratio as of November 2026 (TTM): 19.4